Trilogy International Partners’ (TRL) Outperform Rating Reaffirmed at Scotiabank
Scotiabank reiterated their outperform rating on shares of Trilogy International Partners (TSE:TRL) in a report published on Thursday morning. Scotiabank currently has a C$9.50 price target on the specialty pharmaceutical company’s stock.
Other equities analysts also recently issued research reports about the company. TD Securities increased their price target on Trilogy International Partners from C$9.50 to C$10.00 and gave the company a buy rating in a report on Tuesday, October 24th. Royal Bank Of Canada increased their price objective on Trilogy International Partners from C$9.00 to C$11.00 and gave the company an outperform rating in a research report on Monday, November 13th.
Trilogy International Partners (TSE TRL) opened at C$5.36 on Thursday. Trilogy International Partners has a twelve month low of C$5.19 and a twelve month high of C$10.02.
Trilogy International Partners Company Profile
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.
Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with MarketBeat.com's FREE daily email newsletter.